Lateral Flow Assays Market

Report Code MD 4158
Published in Feb, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Lateral Flow Assays Market by Product (Kit, Readers), Application (STI, Covid-19, Hep, TB, Cardiac marker, Pregnancy; Drug Abuse, Vet Diaganostic, Food), Sample (Blood, Urine, Saliva), Technique (Sandwich, Competitive), End User & Region - Global Forecast to 2029

Overview

The global lateral flow assays market in terms of revenue was estimated to be worth $10.8 billion in 2023 and is poised to reach $16.8 billion by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The rising adoption of kits & reagents and lateral flow assay readers for infectious diseseas testing, veterinary diagnostics, and drug of abuse testing, cardiac marker testing. Whereas most of lateral flow assays are having limitation of qualitative detection, lot to lot variation like factors may hinder the growth of market during the forecast period.

Attractive Opportunities in the Lateral Flow Assays Market

ASIA PACIFIC

Growth in the APAC market can be attributed to the increasing COVID-19 patient volume, increasing healthcare expenditure, rapidly developing healthcare infrastructure, growing geriatric population, and increasing prevalence of infectious diseases in this region.

The high prevalence of infectious diseases worldwide, growing demand for point-of-care testing, and rising use of home-based lateral flow assay devices are the major factors driving the growth of this market.

Emerging markets, technological advancements, and the growing demand for home care and point-of-care testing are lucrative growth opportunities for market players.

The North American lateral flow assays market is projected to reach USD 6,016 million by 2029, at a CAGR of 6.6% during the forecast period.

The clinical testing market is projected to be the largest segment of the lateral flow assays market

Global Lateral Flow Assays Market Dynamics

DRIVER: Increase in eye disorders

Age is the major factor in eye related disorder. The rise in population and increase in chronic exposure to UV screens are influencing the rise in eye-related disorders. The most common diseases include diabetic retinopathy, glaucoma, cataract, corneal opacities, Trachoma, refractive error disease, etc. The rise of diabetic retinopathy, a prevalent challenge for many living with diabetes, has ignited a demand for advanced imaging and laser treatments. These advancements, along with innovative technologies like femtosecond lasers and phacoemulsification systems for cataracts, represent a beacon of hope in the global fight against vision loss. This isn't just a story of market forces; it's a testament to the power of scientific progress in empowering us to protect our precious eyesight. As awareness grows and preventive measures take hold, the need for specialized lateral flow assays is likely to remain strong, fueled by both the apprehension of losing sight and the unwavering desire to preserve it. In North America, there is an estimate that nearly 56 million people will be affected from diabetic retinopathy and will reach 63.2 million. (Source: IDF). On the other hand, according to NIH 2020, approximately 10 million cataract operations are performed every year in the world, with rates varying from 100 to 6000 operations per million population per year. According to the National Eye Institute, about 200,000 new cases of wet AMD are diagnosed each year in North America.

RESTRAINT: rising adoption of previously owned equipment

The market includes a lot of local players that tend to provide refurbished equipment at cost-effective prices. Since the cost associated with this equipment is touching the sky, these local players have gained a large momentum in the past. The true reasons for the adoption of refurbished equipments includeFirst of all, healthcare is becoming increasingly cost-conscious. A growing number of organizations and individual practitioners are looking for more affordable options due to budgetary restrictions and rising equipment costs. Refurbished equipment can provide equivalent performance and reliability to new equipment, which makes it an appealing alternative because it is sometimes much less expensive. Second, improvements in refurbishing technology are making reconditioned equipment last longer and be of higher quality. Reputable refurbishers may guarantee performance that satisfies exacting medical requirements with careful cleaning, recalibration, and replacement of worn parts. Healthcare providers find used equipment more appealing due to its increased reliability. Thirdly, a move towards sustainable practices is being driven by environmental concerns. Refurbishing equipment contributes to waste reduction and equipment longevity, which is in line with the increasing demand for ethical healthcare practices. Thus, the refurbished market is creating a huge barrier for growth.

 

OPPORTUNITY: Low adoption of phacoemulsification devices and premium IOLs in emerging regions

Phacoemulsification is regarded as an important and effective treatment in treating cataract surgeries. It involves the removal of lens by breaking it. It makes cataract surgery safe and effective, and used nearly 60% of the time to treat cataracts of which only 25% is used in Asia. In India, nearly 17% of cataract surgeries are done using this technique and premium lenses are used in only 8% of these surgeries. Reduced reimbursement for use of such high priced lenses and high post operative costs are reasons of low adoption in emerging regions. Thus, it is said that premium lenses at cost effective price would represent a huge market potential in merging regions creating opportunities for growth in the Asia Pacific region and Latin America region. The cost of phacoemulsification equipment and high-end IOLs is much more than that of conventional cataract surgery methods. Basic care is prioritized in settings with limited resources, therefore it might be difficult to justify the increased cost of these cutting-edge devices.Phacoemulsification implementation necessitates operating rooms, specialized equipment, and skilled staff. Lack of these resources prevents widespread adoption in many growing regions. Furthermore, teaching surgeons these intricate methods can be costly and time-consuming. The advantages of high-end IOLs, such as better vision quality and less need for glasses, may not be well recognized or appreciated in areas where basic vision restoration is the main issue. Driving the adoption of these technologies requires educating patients and creating awareness of their benefits.

CHALLENGE: Lack of skilled professionals

The demand for skilled professionals is high, and the actual numbers don’t justify it. This was initially an issue in the emerging regions however it is holding true in the mature markets as well. This leads to a lack of adoption of technologically advanced tools and in turn hampers market growth. As per the All India Ophthalmic Society, in 2019, only 15,000 professionals in the ophthalmology space were treating 1 to 100,000 people. Similarly, in 2021, the American Academy of Ophthalmologists reported 18,000 practicing ophthalmologists in the US only. In the sub Saharan Africa there is an average of 2.5 ophthalmologists for every million patients. Similarly, in China it is 44,000 doctors and only 1.6 doctors for every 50,000 people. Thus, it creates hindrance in the adoption of the improved technology and the user is not skilled enough.

Global Lateral Flow Assays Market Ecosystem Analysis

 

 

Fundus camera is a leader in Ophthalmic ultrasound imaging systems of lateral flow assays industry.

In the market for ophthalmic ultrasound imaging systems, the fundus camera is the industry leader. This is due to its exceptional capacity to reveal the eye's mysteries and facilitate the early identification of diseases that could jeopardize eyesight. There are a number of reasons why it is the clear winner. Fundus cameras, in contrast to other imaging modalities, offer a painless and non-invasive window into the retina, the thin layer of tissue lining the back of the eye. It is perfect for routine checks and for keeping an eye on patients with chronic eye problems because of its ease of use, which permits numerous inspections. The fundus camera offers important insights into the health of the eye by taking high-resolution pictures of the retina, optic nerve, and blood vessels. Early indications of diseases such as diabetic retinopathy, glaucoma, and macular degeneration can be identified with the help of this comprehensive visualization.

The vision care segment accounted for the largest share of the product lateral flow assays industry.

The aging population and growing awareness of eye health are driving a dynamic shift in the lateral flow assays market. Particularly the Asia Pacific area has become a major force, securing the top growth slot for 2022. Many factors, including government programs, technological breakthroughs, and changing lifestyles and demographics, are driving this growth. Using their strengths in manufacturing, aging populations, and preventive healthcare, nations like China, India, and Japan are driving the change. Eye care, which includes eyeglasses, contact lenses, and associated accessories, takes up a sizeable portion of this industry. Key drivers include the widespread demand for refractive error correction, ongoing advancements in lens technologies, affordability, and user-friendliness. However, eye care is only one aspect of the whole picture. Sophisticated surgical instruments, necessary consumables, and diagnostic devices such as autorefractors and tonometers all play vital roles in this complex and dynamic field. As the market for lateral flow assays grows and changes, it is important to make sure that everyone has fair access to high-quality eye care. This entails tackling issues including infrastructure constraints, affordability, and the lack of qualified professionals. In order to guarantee that everyone, regardless of geography or economic status, has the chance to view the world clearly, stakeholders can collaborate to fully utilize the potential of innovation and accessibility.

NORTH AMERICA region holds the largest share of the Lateral Flow Assays Market.

North America has some of the highest worldwide healthcare spending rates, which translates into large investments in state-of-the-art ophthalmic technology. This encourages the creation and uptake of cutting-edge technology, expanding the realm of what is practical for preventive and vision restoration. World-class research facilities and medical centers that are at the forefront of ocular research and development can be found in the area. This creates a vibrant ecosystem that encourages innovation, which results in a steady supply of new and enhanced equipment coming to market. Naturally, as North America's population ages, age-related eye conditions like cataracts and macular degeneration become more common. Growth is further accelerated as a result of the expanded market for diagnostic and therapeutic equipment.

 
 

Recent Developments of Lateral Flow Assays Market industry

  • In August 2023, Quidelortho received authorization from the US Food and Drug Administration (FDA), allowing the company to market its new Sofia 2 SARS Antigen+ FIA. In February 2022, Abbott Laboratories received FDA Emergency Use Authorization (EUA) for its Alinity M assay to detect antibodies to SARS-CoV-2.
  • In October 2022, Roche launched the next-generation portfolio of SARS-CoV-2 rapid antigen tests (“2.0”).

Key Market Players

KEY PLAYERS IN THE Lateral Flow Assays Market INCLUDE

Want to explore hidden markets that can drive new revenue in Lateral Flow Assays Market?

Scope of the Report

Report Attribute Details
Market Revenue in 2023 $10.8 billion
Projected Revenue by 2029 $16.8 billion
Revenue Rate Poised to Grow at a CAGR of 7.6%
Market Driver Increase in eye disorders
Market Opportunity Low adoption of phacoemulsification devices and premium IOLs in emerging regions

Key Questions Addressed by the Report

What is the projected market revenue value of the global lateral flow assays market?
The global lateral flow assays market is projected to reach $16.8 billion by 2029.
What is the estimated growth rate (CAGR) of the global lateral flow assays market?
The market has an estimated CAGR of 7.6% with a revenue size of $10.8 billion in 2023.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Lateral Flow Assays Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
35
RESEARCH METHODOLOGY
40
EXECUTIVE SUMMARY
53
PREMIUM INSIGHTS
57
MARKET OVERVIEW
60
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - High prevalence of infectious diseases
    - Rising geriatric population
    - Growing use of home-based lateral flow assay devices
    - Growing demand for POC testing
    RESTRAINTS
    - Inconsistent results of lateral flow assay tests
    OPPORTUNITIES
    - Evolving applications of lateral flow assays
    - Rising demand for lateral flow assays in food & beverage industry
    - Emergence of Omicron COVID variant
    CHALLENGES
    - Limited reimbursements for lateral flow assay products
    - Difficulties in procuring quality raw materials to develop tests
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.4 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND, BY APPLICATION
    AVERAGE SELLING PRICE TREND, BY REGION
  • 5.5 ECOSYSTEM
  • 5.6 SUPPLY CHAIN ANALYSIS
    PROMINENT COMPANIES
    SMALL & MEDIUM-SIZED COMPANIES
    END USERS
  • 5.7 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS
    TOP APPLICANTS (COMPANIES) OF LATERAL FLOW ASSAY PATENTS
    JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN LATERAL FLOW ASSAYS MARKET
  • 5.8 VALUE CHAIN ANALYSIS
  • 5.9 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGY: LATERAL FLOW ASSAYS
    ADJACENT TECHNOLOGY: ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS)
  • 5.10 CASE STUDY ANALYSIS
    CASE STUDY 1: QUIDEL LAUNCHES NEW TEST WITH BROADER DETECTION WINDOW
    CASE STUDY 2: ABINGTON OFFERS HIGH-SENSITIVITY TESTS FOR GREATER QUALITY
    CASE STUDY 3: SIEMENS OFFERS HIGH-SENSITIVITY TROPONIN I ASSAY TO RAPIDLY DETECT ACUTE MYOCARDIAL INFARCTION
  • 5.11 REGULATORY ANALYSIS
    REGULATORY LANDSCAPE
    - North America
    - Europe
    - Asia
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Rest of the world
  • 5.12 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.13 ADJACENT MARKET ANALYSIS
  • 5.14 KEY CONFERENCES AND EVENTS, 2023–2024
  • 5.15 TRADE ANALYSIS
    IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS
    EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS
  • 5.16 INDUSTRY TRENDS
    DETECTION OF HIV WITH LATERAL FLOW ASSAYS
    INCREASING ADOPTION OF QUANTITATIVE LATERAL FLOW ASSAYS DUE TO AVAILABILITY OF LFA READERS
  • 5.17 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.18 LATERAL FLOW ASSAYS MARKET: IMPACT OF INFLATION AND RECESSION
  • 5.19 ARTIFICIAL INTELLIGENCE (AI) IN LATERAL FLOW ASSAY MARKET
  • 5.20 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.21 INVESTMENT/VENTURE CAPITAL
LATERAL FLOW ASSAYS MARKET, BY PRODUCT
87
  • 6.1 INTRODUCTION
  • 6.2 KITS & REAGENTS
    RISING DEMAND FOR POC TESTING TO DRIVE MARKET
  • 6.3 READERS
    DIGITAL/HANDHELD READERS
    - Technological evolutions and accuracy to drive adoption
    BENCHTOP READERS
    - Lower diagnosis cost per patient to drive adoption
    INSIGHTS ON DISPOSABLE AND REUSABLE LATERAL FLOW ASSAY READERS
    LATERAL FLOW READERS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE
LATERAL FLOW ASSAYS MARKET, BY APPLICATION
98
  • 7.1 INTRODUCTION
  • 7.2 CLINICAL TESTING
    INFECTIOUS DISEASE TESTING
    - Mosquito-borne diseases
    - COVID-19
    - Influenza
    - Sexually transmitted infections
    - Hepatitis
    - Tuberculosis
    - Other infectious diseases
    CARDIAC MARKER TESTING
    - Troponin I & T
    - CK-MB
    - BNP & NT-proBNP
    - Myoglobin
    - D-Dimer
    - Other cardiac marker tests
    PREGNANCY & FERTILITY TESTING
    - Pregnancy testing
    - Fertility testing
    CHOLESTEROL/LIPID TESTING
    - Lifestyle changes, rising obesity prevalence to drive market
    DRUGS-OF-ABUSE TESTING
    - Technological advancements and rising focus on workplace drug testing to drive market
    OTHER CLINICAL TESTS
  • 7.3 VETERINARY DIAGNOSTICS
    INFECTIOUS DISEASE OUTBREAKS TO DRIVE MARKET
  • 7.4 FOOD SAFETY & ENVIRONMENT TESTING
    HIGH SENSITIVITY AND EASE OF USE TO BOOST DEMAND FOR ASSAYS
  • 7.5 DRUG DEVELOPMENT & QUALITY TESTING
    INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO SUPPORT MARKET GROWTH
LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE
148
  • 8.1 INTRODUCTION
  • 8.2 SANDWICH ASSAYS
    WIDE APPLICATIONS IN CLINICAL TESTING TO SUPPORT MARKET GROWTH
  • 8.3 COMPETITIVE ASSAYS
    REDUCED SELECTIVITY AND SENSITIVITY COMPARED TO SANDWICH ASSAYS TO HAMPER GROWTH
  • 8.4 MULTIPLEX DETECTION ASSAYS
    INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET
LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE
155
  • 9.1 INTRODUCTION
  • 9.2 BLOOD SAMPLES
    INCREASING USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE MARKET
  • 9.3 URINE SAMPLES
    GROWING USE OF URINE SAMPLES FOR PREGNANCY AND DRUGS-OF-ABUSE TESTING TO DRIVE MARKET
  • 9.4 SALIVA SAMPLES
    EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES TO SUPPORT ADOPTION
  • 9.5 OTHER SAMPLES
LATERAL FLOW ASSAYS MARKET, BY END USER
161
  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS & CLINICS
    INCREASING USE OF POC TESTS TO DRIVE MARKET
  • 10.3 HOME CARE SETTINGS
    GROWING ACCEPTANCE OF REMOTE MONITORING TO PROPEL MARKET
  • 10.4 DIAGNOSTIC LABORATORIES
    LABORATORY TESTING LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING
  • 10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    INCREASING FOCUS ON PRODUCT SAFETY TO DRIVE ADOPTION OF LATERAL FLOW ASSAYS
  • 10.6 OTHER END USERS
LATERAL FLOW ASSAYS MARKET, BY REGION
169
  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT
    US
    - US to hold largest market share of global market, by country
    CANADA
    - Availability of research funding and implementation of favorable government initiatives to drive market
  • 11.3 EUROPE
    EUROPE: RECESSION IMPACT
    GERMANY
    - Growing number of POC diagnostics centers to drive demand
    FRANCE
    - High prevalence of age-related chronic diseases and infectious diseases to drive market
    UK
    - Rising prevalence of obesity to propel market
    ITALY
    - Growing initiatives toward decentralization of medical services to support market growth
    SPAIN
    - Increasing focus of international organizations and domestic players on developing POC products to aid market growth
    REST OF EUROPE
  • 11.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
    CHINA
    - Growing adoption of lateral flow assays in veterinary diagnostics and drug development to drive market
    JAPAN
    - Increasing prevalence of age-related illnesses to drive market
    INDIA
    - Growing healthcare concerns and rising income levels to propel market growth
    AUSTRALIA
    - Increasing prevalence of infectious diseases, especially influenza, to drive market
    SOUTH KOREA
    REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    LATIN AMERICA: RECESSION IMPACT
    BRAZIL
    - High private healthcare expenditure and rising geriatric population to drive market
    MEXICO
    - High prevalence of obesity and related chronic diseases to propel market
    ARGENTINA
    - Availability of health insurance to favor market growth
    REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TO DRIVE MARKET
    MIDDLE EAST & AFRICA: RECESSION IMPACT
    GCC COUNTRIES
    - GCC countries: Recession impact
COMPETITIVE LANDSCAPE
304
  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.3 REVENUE SHARE ANALYSIS
  • 12.4 MARKET SHARE ANALYSIS
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
    STARS
    PERVASIVE PLAYERS
    EMERGING LEADERS
    PARTICIPANTS
    COMPANY FOOTPRINT
  • 12.6 COMPANY EVALUATION MATRIX: SMES & STARTUPS
    PROGRESSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    RESPONSIVE COMPANIES
    COMPETITIVE BENCHMARKING
  • 12.7 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
    EXPANSIONS
    OTHER DEVELOPMENTS
  • 12.8 R&D ASSESSMENT OF KEY PLAYERS
  • 12.9 INVESTMENT LANDSCAPE
  • 12.10 VALUATION AND FINANCIAL MATRICES
COMPANY PROFILES
324
  • 13.1 KEY PLAYERS
    ABBOTT LABORATORIES
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    F. HOFFMANN-LA ROCHE LTD.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    QUIDELORTHO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    DANAHER CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    SIEMENS AG
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BECTON, DICKINSON AND COMPANY
    - Business overview
    - Products offered
    - Recent developments
    BIOMÉRIEUX SA
    - Business overview
    - Products offered
    - Recent developments
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products offered
    - Recent developments
    PERKINELMER INC.
    - Business overview
    - Products offered
    - Recent developments
    QIAGEN N.V.
    - Business overview
    - Products offered
    - Recent developments
  • 13.2 OTHER PLAYERS
    MERCK KGAA
    HOLOGIC, INC.
    ABCAM PLC
    SURMODICS INC.
    CHEMBIO DIAGNOSTICS, INC. (BIOSYNEX)
    ORASURE TECHNOLOGIES
    DCN DIAGNOSTICS
    POLYSCIENCES INC.
    ABINGDON HEALTH
    ORANOXIS INC.
    AESKU.GROUP GMBH
    BIO GROUP MEDICAL SYSTEM S.R.L
    PHARMACT GMBH
    DIESSE DIAGNOSTICA SENESE S.P.A.
    XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.
APPENDIX
374
  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 2 PREVALENCE OF HIV WORLDWIDE (2017 VS. 2021)
  • TABLE 3 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS
  • TABLE 4 EPIDEMIOLOGICAL UPDATE ON OMICRON VARIANT
  • TABLE 5 EXAMPLES OF LATERAL FLOW ASSAY KITS AVAILABLE TO DETECT OMICRON
  • TABLE 6 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS), BY COMPANY AND APPLICATION, 2021–2023
  • TABLE 7 AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2020 VS. 2022
  • TABLE 8 LATERAL FLOW ASSAYS MARKET: ECOSYSTEM ANALYSIS (2022)
  • TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 15 LATERAL FLOW ASSAYS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • TABLE 16 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 17 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 18 US: HIV PREVALENCE RATE, 2016–2021
  • TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • TABLE 20 POTENTIAL APPLICATIONS OF AI IN LATERAL FLOW ASSAYS
  • TABLE 21 LATERAL FLOW ASSAYS MARKET: UNMET NEEDS/END-USER EXPECTATIONS
  • TABLE 22 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 23 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 24 LATERAL FLOW READERS OFFERED, BY COMPANY
  • TABLE 25 INDICATIVE LIST OF LATERAL FLOW ASSAY KITS & REAGENTS: WITH AND WITHOUT ANALYZERS
  • TABLE 26 LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 27 LATERAL FLOW READERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 28 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION).
  • TABLE 29 BENCHTOP LATERAL FLOW READERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 30 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTICS
  • TABLE 31 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 32 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 33 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 34 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 35 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 36 MAJOR PRODUCTS: DENGUE TESTING
  • TABLE 37 LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 38 COVID-19 (ANTIGEN AND ANTIBODY) LATERAL FLOW ASSAY TESTS
  • TABLE 39 LATERAL FLOW ASSAYS MARKET FOR COVID-19, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 40 LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 41 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 42 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 43 LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 44 LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 45 LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2021–2029
  • TABLE 46 LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 47 LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 48 LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 49 LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 50 LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 51 LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 52 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 53 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 54 LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 55 LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 56 LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 57 LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 58 LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 59 LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 60 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 61 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 62 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 63 LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 64 LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 65 LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 66 LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 67 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 68 LATERAL FLOW ASSAYS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 69 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 70 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 71 LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 72 LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 73 LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 74 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 75 LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 76 LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 77 LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 78 LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 79 LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 80 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 81 LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 82 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 83 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 84 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 85 LATERAL FLOW ASSAYS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 86 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 87 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 89 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 91 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 92 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 94 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 95 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 96 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 97 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 98 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 99 US: MACROECONOMIC INDICATORS
  • TABLE 100 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 101 US: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 102 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 103 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 104 US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 105 US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 106 US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 107 US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 108 US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 109 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 110 US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029USD MILLION)
  • TABLE 111 CANADA: MACROECONOMIC INDICATORS
  • TABLE 112 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 113 CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 114 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 115 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 116 CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 117 CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 118 CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 119 CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 120 CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 121 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 122 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029USD MILLION)
  • TABLE 123 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 124 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 125 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 126 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 127 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 128 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 129 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 130 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 131 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 132 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 133 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 134 EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 135 GERMANY: MACROECONOMIC INDICATORS
  • TABLE 136 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 137 GERMANY: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 138 GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 139 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 140 GERMANY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 141 GERMANY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 142 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 143 GERMANY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 144 GERMANY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 145 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 146 GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 147 FRANCE: MACROECONOMIC INDICATORS
  • TABLE 148 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 149 FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 150 FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 151 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 152 FRANCE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 153 FRANCE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 154 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 155 FRANCE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 156 FRANCE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 157 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 158 FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 159 UK: MACROECONOMIC INDICATORS
  • TABLE 160 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 161 UK: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 162 UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 163 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 164 UK: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 165 UK: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 166 UK: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 167 UK: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 168 UK: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 169 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 170 UK: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 171 ITALY: MACROECONOMIC INDICATORS
  • TABLE 172 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 173 ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 174 ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 175 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 176 ITALY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 177 ITALY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 178 ITALY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 179 ITALY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 180 ITALY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 181 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 182 ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 183 SPAIN: MACROECONOMIC INDICATORS
  • TABLE 184 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 185 SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 186 SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 187 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 188 SPAIN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 189 SPAIN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 190 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 191 SPAIN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 192 SPAIN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 193 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 194 SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 195 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 196 REST OF EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 197 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 198 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 199 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 200 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 201 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 202 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 203 REST OF EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 204 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 205 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 206 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 207 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 208 ASIA PACIFIC: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 209 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 210 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 211 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 212 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 213 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 214 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 215 ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 216 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 217 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 218 CHINA: MACROECONOMIC INDICATORS
  • TABLE 219 CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 220 CHINA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 221 CHINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 222 CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 223 CHINA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 224 CHINA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 225 CHINA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 226 CHINA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 227 CHINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 228 CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 229 CHINA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 230 JAPAN: MACROECONOMIC INDICATORS
  • TABLE 231 JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 232 JAPAN: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 233 JAPAN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 234 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 235 JAPAN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 236 JAPAN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 237 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 238 JAPAN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 239 JAPAN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 240 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 241 JAPAN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 242 INDIA: MACROECONOMIC INDICATORS
  • TABLE 243 INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 244 INDIA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 245 INDIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 246 INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 247 INDIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 248 INDIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 249 INDIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 250 INDIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 251 INDIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 252 INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 253 INDIA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 254 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 255 AUSTRALIA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 256 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 257 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 258 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 259 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 260 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 261 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 262 AUSTRALIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 263 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 264 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 265 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 266 SOUTH KOREA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 267 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 268 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 269 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 270 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 271 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 272 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 273 SOUTH KOREA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 274 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 275 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 276 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 277 REST OF ASIA PACIFIC: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 278 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 279 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 280 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 281 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 282 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 283 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 284 REST OF ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 285 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 286 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 287 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 288 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 289 LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 290 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 291 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 292 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 293 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 294 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 295 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 296 LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 297 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 298 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 299 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 300 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 301 BRAZIL: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 302 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 303 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 304 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 305 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 306 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 307 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 308 BRAZIL: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 309 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 310 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 311 MEXICO: MACROECONOMIC INDICATORS
  • TABLE 312 MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 313 MEXICO: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 314 MEXICO: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 315 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 316 MEXICO: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 317 MEXICO: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 318 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 319 MEXICO: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 320 MEXICO: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 321 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 322 MEXICO: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 323 ARGENTINA: MACROECONOMIC INDICATORS
  • TABLE 324 ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 325 ARGENTINA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 326 ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 327 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 328 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 329 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 330 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 331 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 332 ARGENTINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 333 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 334 ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 335 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 336 REST OF LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 337 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 338 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 339 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 340 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 341 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 342 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 343 REST OF LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 344 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 345 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 346 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 347 MIDDLE EAST & AFRICA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 348 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 349 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 350 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 351 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 352 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 353 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 354 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 355 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 356 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 357 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 358 GCC COUNTRIES: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 359 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 360 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 361 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION)
  • TABLE 362 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 363 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 364 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 365 GCC COUNTRIES: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION)
  • TABLE 366 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION)
  • TABLE 367 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 368 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN LATERAL FLOW ASSAYS MARKET
  • TABLE 369 LATERAL FLOW ASSAYS MARKET: DEGREE OF COMPETITION
  • TABLE 370 PRODUCT FOOTPRINT (25 COMPANIES)
  • TABLE 371 TECHNIQUE FOOTPRINT (25 COMPANIES)
  • TABLE 372 APPLICATION FOOTPRINT (25 COMPANIES)
  • TABLE 373 SAMPLE TYPE FOOTPRINT (25 COMPANIES)
  • TABLE 374 END-USER FOOTPRINT (25 COMPANIES)
  • TABLE 375 REGIONAL FOOTPRINT (25 COMPANIES)
  • TABLE 376 LATERAL FLOW ASSAY MARKET: DETAILED LIST OF KEY STARTUP/SMES
  • TABLE 377 LATERAL FLOW ASSAY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES
  • TABLE 378 LATERAL FLOW ASSAYS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020–DECEMBER 2023
  • TABLE 379 LATERAL FLOW ASSAYS MARKET: DEALS, JANUARY 2020–DECEMBER 2023
  • TABLE 380 LATERAL FLOW ASSAYS MARKET: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
  • TABLE 381 LATERAL FLOW ASSAYS MARKET: OTHER DEVELOPMENTS, JANUARY 2020–DECEMBER 2023
  • TABLE 382 ABBOTT LABORATORIES: COMPANY OVERVIEW
  • TABLE 383 ABBOTT LABORATORIES: PRODUCTS OFFERED
  • TABLE 384 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 385 ABBOTT LABORATORIES: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 386 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
  • TABLE 387 F. HOFFMAN-LA ROCHE: PRODUCTS OFFERED
  • TABLE 388 F. HOFFMAN-LA ROCHE: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 389 F. HOFFMAN-LA ROCHE: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 390 F. HOFFMAN-LA ROCHE: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
  • TABLE 391 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
  • TABLE 392 QUIDELORTHO CORPORATION: PRODUCTS OFFERED
  • TABLE 393 QUIDELORTHO CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 394 QUIDELORTHO CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 395 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 396 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 397 DANAHER CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 398 SIEMENS AG: COMPANY OVERVIEW
  • TABLE 399 SIEMENS AG: PRODUCTS OFFERED
  • TABLE 400 SIEMENS AG: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 401 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 402 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
  • TABLE 403 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 404 BECTON, DICKINSON AND COMPANY: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 405 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
  • TABLE 406 BIOMÉRIEUX SA: COMPANY OVERVIEW
  • TABLE 407 BIOMÉRIEUX SA: PRODUCTS OFFERED
  • TABLE 408 BIOMÉRIEUX SA: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 409 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 410 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 411 THERMO FISHER SCIENTIFIC INC.: PRODUCT APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 412 THERMO FISHER SCIENTIFIC INC.: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 413 PERKINELMER INC.: COMPANY OVERVIEW
  • TABLE 414 PERKINELMER INC.: PRODUCTS OFFERED
  • TABLE 415 PERKINELMER INC.: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
  • TABLE 416 PERKINELMER INC.: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 417 QIAGEN N.V.: COMPANY OVERVIEW
  • TABLE 418 QIAGEN N.V.: PRODUCTS OFFERED
  • TABLE 419 QIAGEN N.V.: DEALS (JANUARY 2020–DECEMBER 2023)
LIST OF FIGURES
 
  • FIGURE 1 LATERAL FLOW ASSAYS MARKET SEGMENTATION
  • FIGURE 2 REGIONAL SCOPE
  • FIGURE 3 RESEARCH DESIGN
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2022)
  • FIGURE 7 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAYS MARKET (2022)
  • FIGURE 8 APPROACH 3: DEMAND-SIDE APPROACH, BASED ON MALARIA LATERAL FLOW TESTING MARKET SIZE (2022)
  • FIGURE 9 APPROACH 4: TOP-DOWN APPROACH
  • FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2029): IMPACT ON MARKET GROWTH AND CAGR
  • FIGURE 11 CAGR PROJECTIONS
  • FIGURE 12 DATA TRIANGULATION METHODOLOGY
  • FIGURE 13 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023 VS. 2029 (USD MILLION)
  • FIGURE 14 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023 VS. 2029 (USD MILLION)
  • FIGURE 15 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION)
  • FIGURE 16 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023 VS. 2029 (USD MILLION)
  • FIGURE 17 LATERAL FLOW ASSAYS MARKET, BY END USER, 2023 VS. 2029 (USD MILLION)
  • FIGURE 18 LATERAL FLOW ASSAYS MARKET: GEOGRAPHICAL SNAPSHOT
  • FIGURE 19 HIGH PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
  • FIGURE 20 ASIA PACIFIC TO REGISTER HIGHEST CAGR OVER FORECAST PERIOD
  • FIGURE 21 CLINICAL TESTING SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • FIGURE 22 CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD
  • FIGURE 23 EMERGING ECONOMIES TO OFFER HIGH GROWTH OPPORTUNITIES IN FORECAST PERIOD
  • FIGURE 24 LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 25 GERIATRIC POPULATION, BY REGION, 2020 VS. 2050 (MILLION)
  • FIGURE 26 GERIATRIC POPULATION, BY REGION, 2022 VS. 2030 VS. 2050 (% OF TOTAL POPULATION)
  • FIGURE 27 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN LATERAL FLOW ASSAYS MARKET, 2013–2023
  • FIGURE 29 TOP COMPANIES THAT APPLIED FOR LATERAL FLOW ASSAY PATENTS, 2016–2022
  • FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAY PATENTS, 2016–2022
  • FIGURE 31 LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS (2022)
  • FIGURE 32 LATERAL FLOW ASSAYS: OVERVIEW OF ADJACENT MARKETS
  • FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • FIGURE 34 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • FIGURE 35 LATERAL FLOW ASSAYS MARKET: INVESTMENT/VENTURE CAPITAL SCENARIO, 2018–2022
  • FIGURE 36 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTICS (2022)
  • FIGURE 37 NORTH MARKET SIZING FOR COVID-19: SCENARIO-BASED FORECASTING
  • FIGURE 38 CHINA TO WITNESS HIGHEST GROWTH IN FORECAST PERIOD
  • FIGURE 39 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT
  • FIGURE 40 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT
  • FIGURE 41 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN PAST FIVE YEARS
  • FIGURE 42 LATERAL FLOW ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
  • FIGURE 43 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
  • FIGURE 44 COMPANY FOOTPRINT (25 COMPANIES)
  • FIGURE 45 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2022
  • FIGURE 46 R&D EXPENDITURE: MAJOR PLAYERS IN LATERAL FLOW ASSAYS MARKET, 2021 VS. 2022
  • FIGURE 47 LATERAL FLOW ASSAY MARKET FUNDING SOARED IN 2022
  • FIGURE 48 MOST VALUED LATERAL FLOW ASSAY FIRMS IN 2022 (USD BILLION)
  • FIGURE 49 LATERAL FLOW ASSAYS MARKET: VALUATION AND FINANCIAL MATRICES
  • FIGURE 50 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
  • FIGURE 51 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
  • FIGURE 52 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 53 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 54 SIEMENS AG: COMPANY SNAPSHOT (2022)
  • FIGURE 55 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
  • FIGURE 56 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2022)
  • FIGURE 57 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 58 PERKINELMER INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 59 QIAGEN N.V.: COMPANY SNAPSHOT (2022)

The study involved four major activities in estimating the current size of the Lateral flow assays Market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary sources referred to for this research study include financial statements of companies offering microfluidics and information from various trade, business, and professional associations. The secondary data was collected and analyzed to arrive at the overall size of the Lateral flow assays Market, which was validated by primary respondents.

Primary Research

Extensive primary research was conducted after obtaining information regarding the Lateral flow assays Market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific,  Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from microfluidics manufacturers; distributors; and key opinion leaders.

Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using microfluidics were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage of lateral flow assays and the future outlook of their business, which will affect the overall market.

Breakdown of Primary Interviews: Supply-Side Participants, By Company Type, Designation, and Region

Lateral Flow Assay Market Size, and Share

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

Note 2: Other primaries include sales managers, marketing managers, and product managers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2020: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=<USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The research methodology used to estimate the size of the Lateral flow assays Market includes the following details.

The market sizing of the market was undertaken from the global side.

Country-level Analysis: The size of the Lateral flow assays Market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products and services in the overall Lateral flow assays Market was obtained from secondary data and validated by primary participants to arrive at the total Lateral flow assays Market. Primary participants further validated the numbers.

Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Lateral flow assays Market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Global Lateral flow assays Market Size: Top-Down Approach

Lateral Flow Assay Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Lateral flow assays Market Size: Bottom-Up Approach

Lateral Flow Assay Market Size, and Share

Data Triangulation

After arriving at the overall size from the market size estimation process explained above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures explained below were implemented, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for various market segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using both the top-down and bottom-up approaches.

Market Definition

Lateral flow assays, also known as lateral flow immunochromatographic assays, are simple-to-use diagnostic devices to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, without the need for specialized equipment. The end users include the Consumers, Hospitals, Specialty Clinics and Ambulatory Surgery Centers and other end Users.

Key Stakeholders

  • Ophthalmology Device Manufacturers
  • Ophthalmology Surgical Devices Manufacturers
  • Ophthalmology Diagnostic & Monitoring Devices Manufacturers
  • Vision Care Products Manufacturers
  • Suppliers and Distributors of Ophthalmology Devices

Report Objectives:

  • To define, describe, and forecast the global lateral flow assays market based on the product, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall lateral flow assays market
  • To analyze opportunities in the global lateral flow assays market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the global lateral flow assays market with respect to five regions—North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
  • To profile key players in the lateral flow assays market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as product launches and approvals, agreements, partnerships, collaborations, acquisitions, joint ventures, spin-offs, expansions, and R&D activities of leading players in the global lateral flow assays market
  • To benchmark players in the market using the “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product strategy within the lateral flow assays market

Available customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the Rest of Europe Lateral flow assays Market into the Netherlands, Austria, Belgium, and others
  • Further breakdown of the Rest of Asia Pacific Lateral flow assays Market into Singapore, Malaysia, and others

Company Information

  • Detailed analysis and profiling of additional market players

Previous Versions of this Report

Lateral Flow Assays Market by Product (Kits, Readers), Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environmental Testing), Technique (Sandwich, Multiplex Detection Assay), End User (Hospitals, Home care) - Global Forecast to 2027

Report Code MD 4158
Published in Feb, 2023, By MarketsandMarkets™

Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker Lipid Test) Veterinary, Food Safety) Product (Readers, Kits) Technique, End User - Global Forecast to 2026

Report Code MD 4158
Published in Dec, 2021, By MarketsandMarkets™

Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker Lipid Test) Veterinary, Food Safety), Product, Technique, End User - Global Forecast to 2025

Report Code MD 4158
Published in Nov, 2020, By MarketsandMarkets™

Lateral Flow Assay Market by Application (Clinical Testing (Pregnancy, Infectious Disease (Mosquito , Influenza, STI, Hepatitis, TB), Cardiac Marker, Lipid Test) Veterinary, Food Safety) Product (Reader, Kits) Technique, End User - Global Forecast to 2023

Report Code MD 4158
Published in Nov, 2018, By MarketsandMarkets™

Lateral Flow Assay Market by Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Multiplex, Sandwich), End User - Global Forecast to 2022

Report Code MD 4158
Published in Aug, 2017, By MarketsandMarkets™

Lateral Flow Assay Market by Product (Reader, Kits) Application (Clinical Testing (Pregnancy, Infectious Disease, Cholestrol, Cardiac Marker), Veterinary, Drug Development) Technique (Sandwich, Competitive, Multiplex) End User - Global Forecast to 2020

Report Code MD 4158
Published in Mar, 2016, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Lateral Flow Assays Market

User

Nov, 2019

this is good.

Max

Oct, 2022

Which factors plays the vital role the global growth of Lateral Flow Assays Market?.

User

Jun, 2018

this is good.

DMCA.com Protection Status